Color Blindness and Color Vision Deficiency

CVD is not one filter. A dichromat, an anomalous trichromat, and someone with acquired blue-yellow loss fail for different biological reasons. This workbench lets you tune the cone defect, run a palette through the simulated observer, and see when color-only information collapses.

Color vision deficiency (CVD) is a reduction in the ability to distinguish colors that most people can tell apart. The word "blindness" is misleading - very few people see no color at all. Most CVD involves a missing or shifted cone pigment, which collapses certain regions of color space onto each other. Reds and greens that look distinct to a trichromat become indistinguishable; yellows and blues may stay clear or may also collapse, depending on which cone is involved.

The deficiency lives in the retina. There is nothing wrong with the eye's optics, the optic nerve, or the visual cortex in inherited CVD - just the photopigment inside one or more cone types. Different cones, different deficiencies.

The most common forms of CVD - protan and deutan - are caused by defects in the L-cone opsin and M-cone opsin genes, which both sit close to each other on the X chromosome at Xq28. The S-cone opsin gene sits on chromosome 7. Because L and M genes are on the X chromosome, their inheritance is sex-linked: men have only one X, so a single defective allele has no backup; women have two, so both copies must carry the defect for the condition to appear.

Several percent of human males are red-green color deficient because the L- and M-opsin genes sit next to each other and share long stretches of identical DNA. During recombination in female meiosis, mispaired copies frequently undergo unequal crossover, producing hybrid or deleted opsin genes. The result is a higher mutation rate at this locus than almost anywhere else in the genome.

CVD is classified by which cone is involved and how badly it is impaired. Each cone deficiency comes in two flavors: -anomaly means the cone exists but its pigment is spectrally shifted; -anopia means the cone is missing or completely non-functional. The clinical impact varies enormously between these two degrees.

Simulation uses linear matrices that approximate the dichromatic projection of color space - the Brettel-Vienot-Mollon model is the standard. The matrices below are first-order approximations. They cannot exactly reproduce a CVD observer's experience, but they show which colors get confused, which is what designers need.

Shinobu Ishihara published his pseudoisochromatic plates in 1917 while serving as a Japanese army surgeon. The design is brilliant in its simplicity: dots of equal lightness but different hues form a number or shape that pops out for normal trichromats but is invisible (or shows as a different number) for specific CVD types. The lightness equalisation prevents brightness from being used as a clue, forcing the observer to rely on hue discrimination alone.

Plotting colors on the CIE chromaticity diagram makes CVD geometrically obvious. Every dichromat has a set of confusion lines - straight lines in the chromaticity diagram along which all colors look the same to them. Each line radiates from a single copunctal point outside the diagram, specific to the deficiency type. Protanopes have one copunctal point; deuteranopes another; tritanopes a third.

The Rayleigh anomaloscope is the gold-standard clinical test for red-green deficiency. Invented by Lord Rayleigh in 1881, it presents a split field: one half is a fixed sodium-yellow (~589 nm); the other half is a mix of red (~671 nm) and green (~546 nm) that the observer adjusts. A normal trichromat makes the match at one narrow ratio. A protanope or deuteranope can match the yellow with any red-green ratio (their match range is very wide). Anomalous trichromats match at a shifted ratio.

Inherited CVD is stable, symmetric between eyes, and usually red-green. Acquired CVD is the opposite: it can appear at any age, often asymmetric, and disproportionately blue-yellow because S-cone signaling is fragile. Tracking a patient's tritan threshold over time is a sensitive way to catch early retinal disease.

Most people with mild CVD never notice. Children with deuteranomaly often go through school without diagnosis, having learned to use brightness, position, and verbal labels to compensate. Severity matters: a strong deutan or protan deficiency produces real friction.

Accessibility for color vision deficiency is largely a design discipline, not a visual one. The goal is to remove dependence on chromatic discrimination wherever possible, and where chromaticity is the natural cue, to choose palettes that survive each common CVD.

A class of optical filters - sold under brands like EnChroma and various competitors - works by absorbing a narrow band of wavelengths where the L and M cones overlap most. The remaining signal forces a wider gap between L and M cone responses, increasing red-green contrast for some anomalous trichromats.

The effect is real but modest, and limited. The glasses do not "cure" color blindness, do not work for dichromats (who lack an entire cone), and shift hues rather than reveal new ones. Many users describe a striking but disorienting experience the first time they try them - reds and greens jumping into starker contrast while other colors look off. Whether the experience translates to lasting benefit in daily life varies widely.

More ambitious approaches are on the horizon. Gene therapy trials have demonstrated that adult macaques can be cured of dichromacy by adding a missing opsin gene via viral vector. Human trials for achromatopsia are underway. Whether the visual system in adult primates can fully integrate a "new" cone class remains an active research question.

Because the L and M opsin genes are X-linked and the genes vary slightly in their spectral peak, women who carry one normal allele and one shifted allele potentially have four distinct cone populations: two slightly different L (or M) plus the others. About 12% of women may be functional tetrachromats by this logic - though demonstrating that the brain actually uses the fourth signal as a separate dimension of color experience is much harder.

Only one carefully documented functional tetrachromat ("cDa29") has been confirmed in the scientific literature, by Gabriele Jordan and colleagues at Newcastle. Her ability to discriminate fine color differences that trichromats cannot suggests the brain can use a fourth cone population - at least sometimes, in at least one person.

Six questions on CVD biology, testing, and design. Wrong answers come with brief explanations.